These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8211900)
41. Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis. Brown MA; Corrigan AB Med J Aust; 1991 Oct; 155(7):493-4. PubMed ID: 1921823 [TBL] [Abstract][Full Text] [Related]
42. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens]. Totokawa S; Furuya T; Nakajima A; Suzuki T; Kashiwazaki S Ryumachi; 1997 Oct; 37(5):681-7. PubMed ID: 9396370 [TBL] [Abstract][Full Text] [Related]
43. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis. Sun CY; Lin HC; Chen YC; Tsai CR; Wu MS Chang Gung Med J; 2006; 29(5):513-7. PubMed ID: 17214397 [TBL] [Abstract][Full Text] [Related]
44. [Pancytopenia related to low-dose methotrexate: study of five cases and review of the literature]. Serraj K; Federici L; Maloisel F; Alt M; Andrès E Rev Med Interne; 2007 Sep; 28(9):584-8. PubMed ID: 17451848 [TBL] [Abstract][Full Text] [Related]
45. Severe bone marrow suppression in a patient with rheumatoid arthritis on methotrexate. Iqbal MP; Ali AA; Alvi AA J Pak Med Assoc; 1993 Dec; 43(12):262-3. PubMed ID: 8133640 [No Abstract] [Full Text] [Related]
46. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Fransen J; Laan RF; Van Der Laar MA; Huizinga TW; Van Riel PL Ann Rheum Dis; 2004 Oct; 63(10):1222-6. PubMed ID: 15361375 [TBL] [Abstract][Full Text] [Related]
47. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate. Wolfe F; Michaud K; Stephenson B; Doyle J J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927 [TBL] [Abstract][Full Text] [Related]
48. Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. Sibilia J; Javier RM; Albert A; Cazenave JP; Kuntz JL J Rheumatol; 1998 Jun; 25(6):1218-20. PubMed ID: 9632090 [TBL] [Abstract][Full Text] [Related]
49. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986 [TBL] [Abstract][Full Text] [Related]
50. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. MacKinnon SK; Starkebaum G; Willkens RF Semin Arthritis Rheum; 1985 Nov; 15(2):119-26. PubMed ID: 3877983 [TBL] [Abstract][Full Text] [Related]
51. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853 [TBL] [Abstract][Full Text] [Related]
52. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
53. [Pancytopenia during low-dose oral methotrexate therapy of psoriatic arthritis]. Kohler S; Neumann J; Dürk H; Saal J; Müller GA Dtsch Med Wochenschr; 1989 Aug; 114(34):1286-8. PubMed ID: 2766951 [TBL] [Abstract][Full Text] [Related]
54. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors. Mameli A; Barcellona D; Marongiu F Am J Ther; 2017; 24(1):e106-e107. PubMed ID: 27574942 [No Abstract] [Full Text] [Related]
56. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity. Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458 [TBL] [Abstract][Full Text] [Related]
57. Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error. Amissah-Arthur MB; Baah W Ghana Med J; 2020 Mar; 54(1):68-71. PubMed ID: 32863415 [TBL] [Abstract][Full Text] [Related]
58. Methotrexate and doxycycline interaction: a rare cause of pancytopenia. Arslan A; Zain MA; Mukhtar M; Ullah W; Roomi S BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154348 [TBL] [Abstract][Full Text] [Related]
59. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis. Ideguchi H; Ohno S; Ishigatsubo Y J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533 [TBL] [Abstract][Full Text] [Related]
60. Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis. Pu T; Ni Y; Li PH; Yu D; Yu Q; Yu LM Am J Med Sci; 2022 Feb; 363(2):185-190. PubMed ID: 34562416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]